Skip to content

Isoxsuprine

CARDIOVASCULAR SYSTEM

Also known as: dilavase, duvadilan, isoxsuprine HCl, isoxsuprine hydrochloride, isoxuprine, vadosilan

FDA approvedATC C04AA01

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Isoxsuprine is a drug catalogued in DrugCentral. Recorded indications include Cerebrovascular disease, Disorder of blood vessel and Raynaud's disease.

  • Indications: Cerebrovascular disease, Disorder of blood vessel and Raynaud's disease.
  • ATC code: C04AA01 (2-amino-1-phenylethanol derivatives).
  • Molecular formula: C18H23NO3; molecular weight 301.39 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (3)

  • Cerebrovascular disease
  • Disorder of blood vessel
  • Raynaud's disease

Off-label uses (1)

  • Dysmenorrhea

Contraindications (3)

  • Arterial hemorrhage
  • Low blood pressure
  • Tachyarrhythmia

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
—FDA——

ATC classification

ATC codeTherapeutic hierarchy
C04AA01CARDIOVASCULAR SYSTEM › PERIPHERAL VASODILATORS › PERIPHERAL VASODILATORS › 2-amino-1-phenylethanol derivatives

Chemical structure

Molecular formulaC18H23NO3
Molecular weight301.39 g/mol
CAS number395-28-8
InChIKeyBMUKKTUHUDJSNZ-UHFFFAOYSA-N
PubChem CID11779629
CC(COC1=CC=CC=C1)NC(C)C(O)C1=CC=C(O)C=C1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Isoxsuprine used for?

DrugCentral lists the following indications for Isoxsuprine: Cerebrovascular disease, Disorder of blood vessel and Raynaud's disease.

What is the chemical formula of Isoxsuprine?

Isoxsuprine has the molecular formula C18H23NO3 and a molecular weight of 301.39 g/mol.

Browse: all drugs starting with I · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval—
AgencyFDA
Targets0
Indications3
FormulaC18H23NO3
DrugCentral ID1510
Interactive profile